144 related articles for article (PubMed ID: 14628085)
1. Binding analysis of HLA-G specific antibodies to hematopoietic cells isolated from leukemia patients.
Poláková K; Bandzuchová E; Hofmeister V; Weiss EH; Hutter H; Russ G
Neoplasma; 2003; 50(5):331-8. PubMed ID: 14628085
[TBL] [Abstract][Full Text] [Related]
2. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
Poláková K; Bennink JR; Yewdell JW; Bystrická M; Bandzuchová E; Russ G
Hum Immunol; 2003 Feb; 64(2):256-64. PubMed ID: 12559628
[TBL] [Abstract][Full Text] [Related]
3. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes.
Poláková K; Kuba D; Russ G
Hum Immunol; 2004 Feb; 65(2):157-62. PubMed ID: 14969770
[TBL] [Abstract][Full Text] [Related]
4. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
[TBL] [Abstract][Full Text] [Related]
5. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.
Ravindranath MH; Taniguchi M; Chen CW; Ozawa M; Kaneku H; El-Awar N; Cai J; Terasaki PI
Mol Immunol; 2010 Feb; 47(5):1121-31. PubMed ID: 19944464
[TBL] [Abstract][Full Text] [Related]
6. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
8. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.
Poláková K; Krcová M; Kuba D; Russ G
Leuk Res; 2003 Jul; 27(7):643-8. PubMed ID: 12681364
[TBL] [Abstract][Full Text] [Related]
9. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.
Poláková K; Russ G
Neoplasma; 2000; 47(6):342-8. PubMed ID: 11263857
[TBL] [Abstract][Full Text] [Related]
10. A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains.
Juch H; Blaschitz A; Daxböck C; Rueckert C; Kofler K; Dohr G
J Immunol Methods; 2005 Dec; 307(1-2):96-106. PubMed ID: 16310801
[TBL] [Abstract][Full Text] [Related]
11. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies.
Zhao L; Teklemariam T; Hantash BM
Tissue Antigens; 2012 Sep; 80(3):231-8. PubMed ID: 22738368
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
14. Lack of HLA-E surface expression is due to deficiency of HLA-E transcripts in the malignant hematopoietic cells of leukemic patients.
Majumder D; Bandyopadhyay D; Chandra S; Mukherjee N; Banerjee S
Leuk Res; 2006 Feb; 30(2):242-5. PubMed ID: 16076489
[No Abstract] [Full Text] [Related]
15. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA-G in the skin of patients with pemphigus vulgaris.
Yari F; Zavaran Hosseini A; Nemat Gorgani M; Khorramizadeh MR; Mansouri P; Kazemnejad A
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):7-12. PubMed ID: 18322306
[TBL] [Abstract][Full Text] [Related]
17. Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies.
Eijsink C; Kester MG; Franke ME; Franken KL; Heemskerk MH; Claas FH; Mulder A
J Immunol Methods; 2006 Aug; 315(1-2):153-61. PubMed ID: 16973172
[TBL] [Abstract][Full Text] [Related]
18. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
20. New monoclonal antibodies specific to HLA class I and their application in the study of acid treatment effect on cell surface antigens.
Karpatová M; Poláková K
Neoplasma; 1992; 39(6):331-6. PubMed ID: 1491721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
